CDK1 Is a Synthetic Lethal Target for KRAS Mutant Tumours
Sara Costa-Cabral(Institute of Cancer Research), Alan Ashworth(University of California, San Francisco)
Cited by 77
Related Papers
Functional Viability Profiles of Breast Cancer
|Cancer Discovery|2011|143
Integrated Functional, Gene Expression and Genomic Analysis for the Identification of Cancer Targets
|PLoS ONE|2009|128
Regulator of G-protein signalling 2 mRNA is differentially expressed in mammary epithelial subpopulations and over-expressed in the majority of breast cancers
|Breast Cancer Research|2007|31
PARP7 Inhibitors and AHR Agonists Act Synergistically across a Wide Range of Cancer Models
|Molecular Cancer Therapeutics|2024|11